SynthesisJournal of robotic surgery2026
Robotic-assisted living-donor hysterectomy for uterus transplantation: a systematic review of surgical techniques, donor safety, and recipient outcomes.
Synthesis in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Uterus transplantation (UTx) has emerged as a promising treatment for women with absolute uterine factor infertility (AUFI), enabling pregnancy and live birth with their own genetic offspring. Living-donor uterus procurement remains the most technically demanding component of the procedure. Robotic-assisted donor hysterectomy has been introduced to improve surgical precision, reduce donor morbidity, and preserve graft quality, while recipient implantation is performed via laparotomy. This systematic review evaluated current evidence on robotic-assisted living-donor hysterectomy for UTx, focusing on surgical techniques, donor safety, recipient outcomes, and reproductive success. Databases and trial registries were searched from inception through June 2026. Six studies reporting 29 unique robotic-assisted living-donor hysterectomies across five countries met the inclusion criteria. All procedures used the da Vinci Xi robotic platform. Operative time and estimated blood loss decreased with increasing surgical experience, while major donor complications (Clavien-Dindo grade III or higher) were less frequent in later series. Among cases with reported follow-up, no graft loss was observed; restoration of menstruation, embryo transfer, clinical pregnancy, and live birth were achieved, including ten live births in the largest programme. Robotic-assisted living-donor hysterectomy for uterus transplantation appears technically feasible and has been associated with viable grafts and successful pregnancies in highly selected cases. However, major donor complications, including ureteric injury requiring reimplantation and bilateral oophorectomy, were observed, and the true incidence of donor morbidity remains uncertain. Current evidence remains limited to small observational studies, and these findings support careful evaluation within structured, multidisciplinary programmes and international registries rather than widespread expansion.
Indexed as
Identifiers
42900394What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.